drugset / Trial / NCT03182088

Norepinephrine Infusion Different Doses in Cesarean Delivery

NCT03182088

Phase 4 Completed 284 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

three doses (0.025 mcg/Kg/min, 0.050 mcg/Kg/min, and 0.075 mcg/Kg/min) of norepinephrine will be compared for prophylaxis against Post-spinal anesthesia hypotension during Cesarean delivery.

Timeline

Start
2017-06-15
Primary completion
2017-12-25
Completion
2017-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.025 ug/kg
Subject Norepinephrine Other / unclassified 0.05 ug/kg
Subject Norepinephrine Other / unclassified 0.075 ug/kg
Background Bupivacaine Other / unclassified 10 mg Intrathecal

Indications

No indication recorded.